AN1 16.7% 0.7¢ anagenics limited

"The respective teams at Roquefort Investments and Lyramid...

  1. 1,276 Posts.
    lightbulb Created with Sketch. 125
    "The respective teams at Roquefort Investments and Lyramid believe the Midkine global patent portfolio has significant unrealised value that can be unlocked through pre-clinical drug development utilising oligonucleotide drugs"

    Stephen West, Executive Chairman

 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $32.31K 4.617M

Buyers (Bids)

No. Vol. Price($)
2 413225 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 15.54pm 20/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.